Feature Review Papers in Pediatric Cardiology and Congenital Heart Disease

A special issue of Journal of Cardiovascular Development and Disease (ISSN 2308-3425). This special issue belongs to the section "Pediatric Cardiology and Congenital Heart Disease".

Deadline for manuscript submissions: 30 June 2024 | Viewed by 2658

Special Issue Editors


E-Mail Website
Guest Editor
Division of Cardiology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO 80045, USA
Interests: pediatric heart failure; microRNA; metabolism; signaling pathways; beta-adrenergic receptor
Pediatric Cardiology and Adult Congenital Heart Unit, Shaare Zedek Medical Center, Jerusalem 9103102, Israel
Interests: pediatric congenital Heart disease; adult congenital heart disease; pulmonary hypertension; cardiac biomarkers in congenital Heart disease

Special Issue Information

Dear Colleagues,

Cardiovascular disease in children is an important medical and health-care-related issue; congenital heart disease and dilated cardiomyopathy are the leading causes of heart failure in children and the primary reason for cardiac transplantation. A number of researchers are already investigating the causes and consequences of heart failure in children, as well as approaches to manage it effectively. Basic, translational and clinical studies have already greatly increased our understanding of this disease; however, there is often limited collaboration between different disciplines. In this Special Issue of JCDD, titled “Pediatric Cardiology and Congenital Heart Disease”, we welcome review papers that summarize the current knowledge of the molecular and cellular processes, as well as novel therapies and disease management, in this population. This issue is open to reviews focused on basic, translational and clinical research on the mechanisms of cardiac disease and therapeutic approaches in the pediatric population, providing a summary of the significant scientific contributions in the field.

Dr. Carmen (Kika) Sucharov
Dr. Amiram Nir
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Cardiovascular Development and Disease is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • congenital heart disease
  • cardiomyopathy
  • heart failure
  • pediatric

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

14 pages, 669 KiB  
Review
A Systematic Approach for the Interpretation of Cardiopulmonary Exercise Testing in Children with Focus on Cardiovascular Diseases
by Bibhuti B. Das
J. Cardiovasc. Dev. Dis. 2023, 10(4), 178; https://doi.org/10.3390/jcdd10040178 - 19 Apr 2023
Cited by 3 | Viewed by 2326
Abstract
Cardiopulmonary exercise testing (CPET) is the clinical standard for children with congenital heart disease (CHD), heart failure (HF) being assessed for transplantation candidacy, and subjects with unexplained dyspnea on exertion. Heart, lung, skeletal muscle, peripheral vasculature, and cellular metabolism impairment frequently lead to [...] Read more.
Cardiopulmonary exercise testing (CPET) is the clinical standard for children with congenital heart disease (CHD), heart failure (HF) being assessed for transplantation candidacy, and subjects with unexplained dyspnea on exertion. Heart, lung, skeletal muscle, peripheral vasculature, and cellular metabolism impairment frequently lead to circulatory, ventilatory, and gas exchange abnormalities during exercise. An integrated analysis of the multi-system response to exercise can be beneficial for differential diagnosis of exercise intolerance. The CPET combines standard graded cardiovascular stress testing with simultaneous ventilatory respired gas analysis. This review addresses the interpretation and clinical significance of CPET results with specific reference to cardiovascular diseases. The diagnostic values of commonly obtained CPET variables are discussed using an easy-to-use algorithm for physicians and trained nonphysician personnel in clinical practice. Full article
Show Figures

Figure 1

Back to TopTop